tak 779 has been researched along with tak-220 in 3 studies
| Studies (tak 779) | Trials (tak 779) | Recent Studies (post-2010) (tak 779) | Studies (tak-220) | Trials (tak-220) | Recent Studies (post-2010) (tak-220) |
|---|---|---|---|---|---|
| 118 | 1 | 35 | 8 | 0 | 3 |
| Protein | Taxonomy | tak 779 (IC50) | tak-220 (IC50) |
|---|---|---|---|
| C-C chemokine receptor type 5 | Homo sapiens (human) | 0.002 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, M; Miyake, H; Okamoto, M; Takashima, K; Wang, X | 1 |
| Fujisawa, J; Furuta, RA; Kanzaki, N; Nishi, T; Nishikawa, M; Takashima, K; Yamamoto, Y | 1 |
| Dioszegi, M; Ji, C; Kondru, R; Mirzadegan, T; Rotstein, D; Sankuratri, S; Zhang, J | 1 |
3 other study(ies) available for tak 779 and tak-220
| Article | Year |
|---|---|
Isolation and characterization of human immunodeficiency virus type 1 resistant to the small-molecule CCR5 antagonist TAK-652.
Topics: Amino Acid Sequence; Anti-HIV Agents; CCR5 Receptor Antagonists; Cells, Cultured; Cytopathogenic Effect, Viral; Drug Resistance, Viral; HIV Infections; HIV-1; Humans; Imidazoles; Leukocytes, Mononuclear; Molecular Sequence Data; Sulfoxides; Virus Replication | 2007 |
Analysis of binding sites for the new small-molecule CCR5 antagonist TAK-220 on human CCR5.
Topics: Amides; Amino Acid Sequence; Anti-HIV Agents; Binding Sites; CCR5 Receptor Antagonists; HIV-1; Humans; Models, Molecular; Molecular Sequence Data; Mutation; Piperidines; Quaternary Ammonium Compounds; Receptors, CCR5 | 2005 |
Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonists.
Topics: Amides; Amino Acid Sequence; Animals; Anti-HIV Agents; Benzoates; Binding Sites; CCR5 Receptor Antagonists; CHO Cells; Cricetinae; Cricetulus; Cyclohexanes; Diketopiperazines; HIV Fusion Inhibitors; HIV-1; Humans; Hydrophobic and Hydrophilic Interactions; Inhibitory Concentration 50; Maraviroc; Membrane Fusion; Models, Molecular; Molecular Sequence Data; Molecular Structure; Mutagenesis, Site-Directed; Piperazines; Piperidines; Protein Structure, Secondary; Protein Structure, Tertiary; Pyrimidines; Quaternary Ammonium Compounds; Radioligand Assay; Receptors, CCR5; Sequence Homology, Amino Acid; Spiro Compounds; Static Electricity; Transfection; Triazoles | 2008 |